Metabolic research
SLU-PP-332
Lyophilized metabolic research compound
SLU-PP-332 is an ERR-pathway research compound studied in exercise-mimetic and metabolic adaptation literature.
Support can confirm any currently available COAs or batch documentation for this product.
Request available documentsConfirm an optional email signup to receive a single-use 10% welcome code.
Get catalog updatesSomente para uso em pesquisa laboratorial. Não é para uso humano ou veterinário. Não se destina a diagnosticar, tratar, curar, mitigar ou prevenir doenças.
Mantenha selado, frio, seco e protegido de oscilações de calor. Confirme o armazenamento específico do produto na chegada.
Embalado para estabilidade de trânsito com suporte para pedidos disponível para rotas em clima quente.
Batch-linked certificate support is available through the documentation desk.
Contexto de pesquisa
Perfil de pesquisa de SLU-PP-332
SLU-PP-332 is a small-molecule research compound associated with estrogen-related receptor signaling rather than a peptide hormone pathway. Preclinical studies use it to investigate oxidative metabolism, mitochondrial gene programs, skeletal-muscle adaptation, energy expenditure, and exercise-mimetic phenotypes. The ERR family helps regulate transcriptional networks involved in cellular energy use, so studies often measure gene expression, mitochondrial markers, endurance-related endpoints, and tissue-specific metabolic changes. This compound is best suited to mechanistic cell and animal research that specifically requires an ERR-pathway agonist. The published evidence is preclinical, and experimental findings do not establish human safety, effectiveness, or an appropriate personal-use context.
Molecular class
Synthetic estrogen-related receptor agonist
Sequence / composition
A synthetic small molecule, not a peptide; its chemical scaffold is used to probe ERR transcriptional programs.
Research design note
Research should separate direct ERR engagement from downstream mitochondrial and metabolic transcriptional responses.
Mecanismo proposto
A synthetic agonist reported to activate estrogen-related receptors, especially ERRalpha, ERRbeta, and ERRgamma. ERR activation regulates transcriptional programs involved in mitochondrial biogenesis, oxidative phosphorylation, fatty-acid oxidation, and oxidative muscle-fiber identity.
Efeitos relatados em estudos
- Cell studies reported induction of ERR-regulated oxidative and mitochondrial gene programs.
- Mouse studies reported increased oxidative muscle characteristics, endurance, energy expenditure, and resistance to diet-related metabolic changes.
- The compound is a small molecule rather than a peptide, and no established human efficacy or safety profile exists.
Desfechos comuns de pesquisa
ERR transcriptional activity, mitochondrial genes, oxygen consumption, fatty-acid oxidation, muscle-fiber type, exercise capacity, energy expenditure, glucose tolerance, and body composition.
Evidências e limitações
Evidence is limited to mechanistic and animal research. Human effects, pharmacokinetics, and safety remain unestablished.
External reading
Literature for context—not product proof.
Third-party sources describe their own research materials and methods. They do not validate a specific Azure catalog batch.
Support and documentation
Questions about this product?
Where can I find product documentation?
Contact support with the product name and any relevant order or batch reference to request available documents.
How can I compare pack options?
Where multiple pack sizes are available, Azure shows the price per listed vial so you can compare catalog value directly.